News

Pharmabiz1m
MSMEs raise their concerns in a discussion organised by NITI Aayog
The micro, small and medium enterprises (MSME) in pharma sector has reported various concerns and challenges they face including the issues related to the No of Standard Quality (NSQ) reporting, need ...
Pharmabiz29m
Boehringer Ingelheim begins THULITE phase II study of BI 1815368, a potential oral treatment for diabetic macular edema
Ingelheim, Germany Tuesday, July 8, 2025, 14:00 Hrs [IST] ...
Pharmabiz44m
FIP World Pharmacists Day 2025 to highlight the vital role of pharmacists in sustainable healthcare systems
FIP World Pharmacists Day 2025 to highlight the vital role of pharmacists in sustainable healthcare systems: Our Bureau, Bengaluru Tuesday, July 8, 2025, 13:45 Hrs [IST] Internati ...
Pharmabiz1h
Sai Parenterals secures Rs. 50 crore equity investment from marquee investors
Sai Parenterals secures Rs. 50 crore equity investment from marquee investors: Our Bureau, Bengaluru Tuesday, July 8, 2025, 13:15 Hrs [IST] Sai Parenterals has completed a Rs. 50 ...
Pharmabiz1h
Sun Pharma confirms the stocks of 'Levipil 500' seized by Telangana DCA in raids is spurious
Sun Pharma confirms the stocks of 'Levipil 500' seized by Telangana DCA in raids is spurious: Our Bureau, Chennai Tuesday, July 8, 2025, 12:45 Hrs [IST] In a significant regulator ...
Pharmabiz2h
HotSpot presents preclinical data from small molecule CBM signalosome inhibitor programme at ESMO Gastrointestinal Cancers Congress 2025
In combination with a KRAS inhibitor, HotSpot’s CBM signalosome inhibitor achieved complete suppression of downstream signalling in KRASG12X cell lines. HotSpot’s CBM signalosome inhibitor ...
Pharmabiz3h
Boston Scientific receives US FDA approval for expanded labelling of Farapulse PFA System
Boston Scientific receives US FDA approval for expanded labelling of Farapulse PFA System: Marlborough, Massachusetts Tuesday, July 8, 2025, 11:00 Hrs [IST] Boston Scientific Corp ...
Pharmabiz4h
Onco-Innovations inks agreement with Nucro-Technics for IND-enabling studies
Onco-Innovations inks agreement with Nucro-Technics for IND-enabling studies: Vancouver, Canada Tuesday, July 8, 2025, 10:00 Hrs [IST] Onco-Innovations Limited, a Canadian-based c ...
Pharmabiz5h
Chugai Pharma and Gero sign joint research and license agreement to develop novel therapies for age-related diseases
Chugai Pharma and Gero sign joint research and license agreement to develop novel therapies for age-related diseases: Tokyo Tuesday, July 8, 2025, 09:00 Hrs [IST] Chugai Pharmaceu ...
Pharmabiz6h
DoC reviews, discusses key issues with stakeholders in exports, imports, trade data and regulations
DoC reviews, discusses key issues with stakeholders in exports, imports, trade data and regulations: Shardul Nautiyal, Mumbai Tuesday, July 8, 2025, 08:00 Hrs [IST] In order to ad ...
Pharmabiz6h
NPPA notifies retail prices of 71 formulations
The National Pharmaceutical Pricing Authority (NPPA) has notified the retail prices of 71 formulations as per the provisions to set prices of new drugs under the Drugs Prices Control Order (DPCO), ...
Pharmabiz6h
NPPA notifies separate retail price of GSK's cold medicine
The National Pharmaceutical Pricing Authority (NPPA) has notified the separate retail price of GlaxoSmithKline (GSK) Asia's cold medicine combination paracetamol 500 mg and phenylephrine HCl 10 mg at ...